From Mendel to Medical Genetics: Milan Macek Jr. to Share Rare Disease Insights at ECTH 2025
European Congress on Thrombosis and Haemostasis (ECTH) posted on LinkedIn:
”From the legacy of Mendel to the frontlines of rare disease advocacy, Professor Milan Macek Jr., MD, DSc, is a true pioneer in medical genetics. As chair of the Czech Republic’s largest academic genetics centre and head of the National Coordination Centre for Rare Diseases, he’s shaping not just science, but national health strategies.
At ECTH 2025, Professor Milan Macek Jr. will take us on a journey through his session “From Mendel to medical genetics”, exploring how genetic breakthroughs are transforming diagnostics, care, and policy for rare diseases.
Expect a session that’s as visionary as it is practical; bridging history, cutting-edge research, and the real-world impact of coordinated action.
Join us at ECTH 2025.”

Stay updated with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series